It was reported that the vns patient who is enrolled in the (b)(6) clinical study presented with syncope which required hospitalization.The treating physician believes the syncope event is probably related to stimulation of the vns device.The patient was implanted with the device in (b)(6) 2012, and the syncope events began on (b)(6) 2014.During hospitalization, the patient regained consciousness in about five minutes without any episode, but had sudden onset of loss of consciousness on the same day, while still in the hospital.The patient regained consciousness and an ecg showed intermittent atrial fibrillation.The ecg also revealed sustained monomorphic ventricular tachycardia.The physician does not believe that the tachycardia event is related to vns stimulation.An electrophysiologist advised for aicd (automatic implantable cardioverter defibrillator) implantation which was done on (b)(6) 2014.The patient was hemodynamically stable during and after the procedure.The patient was discharged in a stable condition on (b)(6) 2014.To note, this patient is enrolled in the (b)(6) clinical study sponsored by the manufacturer and the patient has a known medical history of hypertension & coronary artery disease and moderate left ventricular dysfunction (35%).In addition the patient presents with history of shortness of breath functional classification iii as of the prior 2 ¿ 3 months.
|